Fig. 4.
CML-DCs are defective in presentation at suboptimal dose of peptide.
DCs were generated from healthy individuals (○) and from CML patients (●): patient 1 (A-C) and patient 2 (D-F). Immature HLA-DR7–expressing DCs were pulsed overnight with 3 different doses of peptide HA307-319 (1 μg/mL [A,D]; 0.1 μg/mL [B,E]; 0.01 μg/mL [C,F]). Different numbers of irradiated and prepulsed DCs were cultured in the presence of HA307-319–specific T-cell clone (7P24). The data are expressed as counts per minute (cpm) ± standard deviations (SD). Data are representative of 5 experiments.